Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 95 for “"rAAV"”.
-
Molekular- und zellbiologische Charakterisierung des rAAV-vermittelten Gentargetings
… Eigenschaften sind rekombinante AAV-Vektoren (rAAV) geradezu als Gentherapievektoren prädestiniert. Ziel meiner Arbeit war die Etablierung eines rAAV-vermittelten Gentargeting-Systems, das als proof of principle System verwendet wurde, um ein defektes egfp-Gen über Homologe Rekombination (HR) …
-
Investigating recombinant AAV (rAAV) gene therapy viral vector production
… purposes, the production of recombinant AAV (rAAV) is often achieved via triple transient co-transfection of three plasmids into a mammalian host cell line, such as HEK293 cells. The three plasmids co-transfected most often contain AAV Rep and Cap genes, adenoviral genes, and the target …
-
Evaluating Properties of Dystrophin and Delivery Methods of rAAV Gene Therapy for Duchenne Muscular Dystrophy
… muscle. Recombinant adeno-associated viral (rAAV) vectors have shown promise as a method for delivering therapeutic genes to dystrophic muscles. Vectors expressing miniaturized, or micro-, dystrophin proteins have repeatedly demonstrated rescue of rodent dystrophic animal models as well as …
-
A synthetic approach to produce recombinant adeno-associated virus (rAAV) in Chinese hamster ovary (CHO) cells
Recombinant adeno-associated virus (rAAV) is one of the most promising gene delivery vectors for somatic gene therapy. Currently, its prevailing manufacturing technologies are relying on transiently transfecting host cells with three plasmids or infection of producer cell lines with helper viruses. …
-
Engineering inducible cell lines for recombinant Adeno-Associated Virus production
The recombinant adeno-associated virus (rAAV) gene therapy field has experienced landmark regulatory approvals in recent years by demonstrating high efficacy in treating monogenic diseases. There is therefore an immediate and increasing need for highly productive manufacturing platforms to generate …
-
Generation of clinical grade recombinant adeno-associated virus
Recombinant adeno-associated viruses (rAAV) remain one of the most encouraging gene therapy vectors for treating patients with genetic abnormalities. rAAV can safely deliver long-lasting expression of a therapeutic transgene to a wide range of cell types. One challenge with therapeutic rAAV is the …
-
Interaction between the DNA repair machinery and the adeno-associated virus (AAV) : vector transduction and site-specific integration
… of recombinant vectors derived from this virus (rAAV) in gene transfer applications, several aspects of the biology of both the wild type virus and of its vectors remain poorly understood. Here we developed a technique to visualize the conversion of rAAV vector genomes from single-stranded (ss) …
-
Improving the immunogenicity of recombinant adeno-associated virus
Recombinant adeno-associated virus (rAAV) has many attractive features as a T cell vaccine vector, however disappointing immunogenicity was seen in a phase I clinical trial. Subsequent in vivo studies showed that several pseudotypes of rAAV elicited a dysfunctional CD8+ T cell response in mice that …
-
Developing recombinant adeno-associated virus producer cell lines through systems synthetic biology
Recombinant adeno-associated virus (rAAV) is one of the most widely used vehicles for gene therapy due to its effectiveness in in vivo gene delivery, long-term persistency, and safety. In general, a very large dose of rAAV is required in clinical applications, hence manufacturing is anticipated to …
-
Development of a self-silencing adenovirus for the efficient manufacture of adeno-associated virus vectors
… method used to produce recombinant AAV (rAAV) for pre-clinical/clinical application is based on plasmid transfection of HEK293 cells to provide all the components required for rAAV replication. While versatile and easy to adopt, the helper-free method is limited by a lack of scalability …
-
INVESTIGATING RECOMBINANT AND WILD-TYPE ADENO-ASSOCIATED VIRUS INTEGRATIONS IN THE MACAQUE AND HUMAN GENOMES FOLLOWING IN VIVO EXPOSURE
… both wild-type AAV (wtAAV) and recombinant AAV (rAAV) have been observed in host genomes for over two decades, raising concerns about genotoxicity and clonal expansion in rAAV-treated mice and dogs. Whether in vivo rAAV integration in primates mirrors non-pathogenic wtAAV integration or presents …
-
Integrated metrology approaches for the characterisation of recombinant adeno-associated viral vectors: from molecular assays to mass spectrometry
… of recombinant adeno-associated viral (rAAV) vector products for therapeutic use is essential to ensure the safety and efficacy of gene therapies. However, several current analytical techniques used to assess the critical quality attributes (CQAs) have limitations, such as low precision, …
-
Functional dynamics of the membrane-associated accessory protein (MAAP) during adeno-associated virus (AAV) infection and its implications for recombinant AAV (rAAV) vector production
… the role of SNARE proteins in recombinant AAV (rAAV) vector production through interaction with the viral MAAP; 4) Conclusion. Chapter 1 presents a literature review of AAV life cycle, including virus entry, intracellular trafficking, viral DNA replication, mRNA transcription and translation, …
-
Métodos de modificación génica dirigida en células humanas y su aplicación en el Síndrome de Wiskott-Aldrich
… generamos un virus adenoasociado recombinante (rAAV), que contenía el gen EGFP truncado en 5´. Utilizando la RCL y el rAAV, junto con nucleasas TALEs, estudiamos una proteína de fusión y una librería de siRNAs para incrementar la frecuencia de recombinación homóloga (RH). Habiendo determinado …
-
The impact of hypothalamic overexpression of Makorin ring finger protein 3 (MKRN3) in postpubertal mice
… using a recombinant adeno-associated virus (rAAV-Mkrn3) that was stereotaxically injected bilaterally, targeting the arcuate nucleus of wild-type C57/B6 postpubertal male and female mice. A control group of mice was also injected with the virus (rAAV-EGFP), in which EGFP is enhanced green …
-
Μελέτη της αυτοφαγίας διαμεσολαβούμενης από μοριακές συνοδούς στο νευροεκφυλισμό
… που στοχεύει επιλεκτικά τον υποδοχέα LAMP2A (L2 rAAV), συγκριτικά με τον ιό μάρτυρα scrambled (SCR rAAV) που δε στοχεύει κανένα μετάγραφο. Επιπρόσθετα, δεδομένα πρωτεομικής ανάλυσης σε πρωτογενείς φλοιϊκούς νευρώνες επίμυος με αναστολή του μονοπατιού της CMA έδειξαν μειωμένα επίπεδα της πρωτεΐνης …
-
Expansion of neural stem cells as a treatment for ischemic stroke
… Mal ein rekombinanter Adeno-assoziierter Virus (rAAV) Serotyp identifiziert, der die Transduktion von sowohl SGZ als auch SVZ NSZs ermöglichte. In der SVZ resultierte die 4D Überexpression in einer erhöhten NSZ Proliferation und Neurogenese, was einen grundlegenden Beweis für das rAAV-4D System …
-
Understanding the cellular mechanism of Adeno-Associated Virus genome stabilization
… clinical trials using recombinant AAV vectors (rAAV) have identified the following concerns that need to be addressed in order to increase efficiency of these vectors. It has since been determined that AAV vector efficiency decreases due to the following mechanisms: ineffective endocytosis, …
Page 1 of 5